Daratumumab: A drug with transfusion dilemma
Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma (RRMM). DARA interferes with blood compatibility testing by causing incompatible results while crossmatching by antihuman globulin phase and presenting as a panagglutination...
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Global Journal of Transfusion Medicine |
| Subjects: | |
| Acceso en liña: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=2;spage=222;epage=226;aulast=Biswas |